Dextran‐based priming solution during cardiopulmonary bypass attenuates renal tubular injury—A secondary analysis of randomized controlled trial in adult cardiac surgery patients

MLA

Anders Thorén, et al. “Dextran‐based Priming Solution during Cardiopulmonary Bypass Attenuates Renal Tubular Injury—A Secondary Analysis of Randomized Controlled Trial in Adult Cardiac Surgery Patients.” Acta Anaesthesiologica Scandinavica, vol. 66, Sept. 2021, pp. 40–47. EBSCOhost, https://doi.org/10.1111/aas.13975.

APA

Anders Thorén, Kerstin Björk, Sven-Erik Ricksten, Anders Jeppsson, Anna Corderfeldt, Oscar Kolsrud, Göran Dellgren, & Mikael Barbu. (2021). Dextran‐based priming solution during cardiopulmonary bypass attenuates renal tubular injury—A secondary analysis of randomized controlled trial in adult cardiac surgery patients. Acta Anaesthesiologica Scandinavica, 66, 40–47. https://doi.org/10.1111/aas.13975

Chicago

Anders Thorén, Kerstin Björk, Sven-Erik Ricksten, Anders Jeppsson, Anna Corderfeldt, Oscar Kolsrud, Göran Dellgren, and Mikael Barbu. 2021. “Dextran‐based Priming Solution during Cardiopulmonary Bypass Attenuates Renal Tubular Injury—A Secondary Analysis of Randomized Controlled Trial in Adult Cardiac Surgery Patients.” Acta Anaesthesiologica Scandinavica 66 (September): 40–47. doi:10.1111/aas.13975.